Filing Details
- Accession Number:
- 0001694665-23-000053
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-10 21:31:52
- Reporting Period:
- 2023-05-08
- Accepted Time:
- 2023-05-10 21:31:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1694665 | Evelo Biosciences Inc. | EVLO | Pharmaceutical Preparations (2834) | 465594527 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1738885 | Mark Bodmer | C/O Evelo Biosciences, Inc. 620 Memorial Drive Cambridge MA 02139 | Cso, President Of R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-05-08 | 68,014 | $0.13 | 285,128 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into by the Reporting Person on December 16, 2022, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
- The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices within the range of $0.12 to $0.13, inclusive. The reporting person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.
Billionaire Hedge Funds
